{"id":"https://openalex.org/W1991920463","doi":"https://doi.org/10.1007/s11745-011-3596-3","title":"ApoB siRNA\u2010induced Liver Steatosis is Resistant to Clearance by the Loss of Fatty Acid Transport Protein 5 (Fatp5)","display_name":"ApoB siRNA\u2010induced Liver Steatosis is Resistant to Clearance by the Loss of Fatty Acid Transport Protein 5 (Fatp5)","publication_year":2011,"publication_date":"2011-08-08","ids":{"openalex":"https://openalex.org/W1991920463","doi":"https://doi.org/10.1007/s11745-011-3596-3","mag":"1991920463","pmid":"https://pubmed.ncbi.nlm.nih.gov/21826528","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3213337"},"language":"en","primary_location":{"id":"doi:10.1007/s11745-011-3596-3","doi":"https://doi.org/10.1007/s11745-011-3596-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11745-011-3596-3","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1007/s11745-011-3596-3","source":{"id":"https://openalex.org/S115623499","display_name":"Lipids","issn_l":"0024-4201","issn":["0024-4201","1558-9307"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lipids","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1007/s11745-011-3596-3","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060630096","display_name":"Brandon L. Ason","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Brandon Ason","raw_affiliation_strings":["Amgen Inc. 1120 Veterans Blvd San Francisco CA 94080 USA","Sirna Therapeutics/Merck & Co. Inc. San Francisco CA 94158 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc. 1120 Veterans Blvd San Francisco CA 94080 USA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Sirna Therapeutics/Merck & Co. Inc. San Francisco CA 94158 USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091723829","display_name":"Jose M. Castro\u2010Perez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I121797337","display_name":"Leiden University","ror":"https://ror.org/027bh9e22","country_code":"NL","type":"education","lineage":["https://openalex.org/I121797337"]},{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["NL","US"],"is_corresponding":false,"raw_author_name":"Jose Castro\u2010Perez","raw_affiliation_strings":["Division of Analytical Biosciences LACDR, Leiden University P.O. Box 9502, 2300 RA Leiden The Netherlands","Division of Cardiovascular Diseases and Atherosclerosis Merck Research Laboratories Rahway NJ 07065 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Analytical Biosciences LACDR, Leiden University P.O. Box 9502, 2300 RA Leiden The Netherlands","institution_ids":["https://openalex.org/I121797337"]},{"raw_affiliation_string":"Division of Cardiovascular Diseases and Atherosclerosis Merck Research Laboratories Rahway NJ 07065 USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079507236","display_name":"Samnang Tep","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samnang Tep","raw_affiliation_strings":["Sirna Therapeutics/Merck & Co. Inc. San Francisco CA 94158 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sirna Therapeutics/Merck & Co. Inc. San Francisco CA 94158 USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061646508","display_name":"Alice C. Stefanni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alice Stefanni","raw_affiliation_strings":["Division of Cardiovascular Diseases and Atherosclerosis Merck Research Laboratories Rahway NJ 07065 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiovascular Diseases and Atherosclerosis Merck Research Laboratories Rahway NJ 07065 USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057976002","display_name":"Marija Tadin\u2010Strapps","orcid":"https://orcid.org/0009-0006-2430-8116","observed_orcids":["https://orcid.org/0009-0006-2430-8116"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marija Tadin\u2010Strapps","raw_affiliation_strings":["Sirna Therapeutics/Merck & Co. Inc. San Francisco CA 94158 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sirna Therapeutics/Merck & Co. Inc. San Francisco CA 94158 USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073022316","display_name":"Thomas P. Roddy","orcid":"https://orcid.org/0009-0005-1143-6840","observed_orcids":["https://orcid.org/0009-0005-1143-6840"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Roddy","raw_affiliation_strings":["Division of Cardiovascular Diseases and Atherosclerosis Merck Research Laboratories Rahway NJ 07065 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiovascular Diseases and Atherosclerosis Merck Research Laboratories Rahway NJ 07065 USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076255429","display_name":"Thomas Hankemeier","orcid":"https://orcid.org/0000-0001-7871-2073","observed_orcids":["https://orcid.org/0000-0001-7871-2073"]},"institutions":[{"id":"https://openalex.org/I121797337","display_name":"Leiden University","ror":"https://ror.org/027bh9e22","country_code":"NL","type":"education","lineage":["https://openalex.org/I121797337"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Thomas Hankemeier","raw_affiliation_strings":["Division of Analytical Biosciences LACDR, Leiden University P.O. Box 9502, 2300 RA Leiden The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Analytical Biosciences LACDR, Leiden University P.O. Box 9502, 2300 RA Leiden The Netherlands","institution_ids":["https://openalex.org/I121797337"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069133442","display_name":"Brian K. Hubbard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Hubbard","raw_affiliation_strings":["Division of Cardiovascular Diseases and Atherosclerosis Merck Research Laboratories Rahway NJ 07065 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiovascular Diseases and Atherosclerosis Merck Research Laboratories Rahway NJ 07065 USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108486767","display_name":"Alan B. Sachs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan B. Sachs","raw_affiliation_strings":["Sirna Therapeutics/Merck & Co. Inc. San Francisco CA 94158 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sirna Therapeutics/Merck & Co. Inc. San Francisco CA 94158 USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109888171","display_name":"W. Michael Flanagan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Michael Flanagan","raw_affiliation_strings":["Sirna Therapeutics/Merck & Co. Inc. San Francisco CA 94158 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sirna Therapeutics/Merck & Co. Inc. San Francisco CA 94158 USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039408547","display_name":"Nelly A. Kuklin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nelly A. Kuklin","raw_affiliation_strings":["Sirna Therapeutics/Merck & Co. Inc. San Francisco CA 94158 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sirna Therapeutics/Merck & Co. Inc. San Francisco CA 94158 USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112237253","display_name":"Lyndon J. Mitnaul","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lyndon J. Mitnaul","raw_affiliation_strings":["Division of Cardiovascular Diseases and Atherosclerosis Merck Research Laboratories Rahway NJ 07065 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiovascular Diseases and Atherosclerosis Merck Research Laboratories Rahway NJ 07065 USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5060630096"],"corresponding_institution_ids":["https://openalex.org/I1285764155","https://openalex.org/I1320553840"],"apc_list":{"value":3589,"currency":"USD","value_usd":3589},"apc_paid":null,"fwci":2.0471,"has_fulltext":true,"cited_by_count":39,"citation_normalized_percentile":{"value":0.86555601,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"46","issue":"11","first_page":"991","last_page":"1003"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.7411999702453613,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.7411999702453613,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.13120000064373016,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.08370000123977661,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.9869999885559082},{"id":"https://openalex.org/keywords/hepatic-steatosis","display_name":"hepatic steatosis","score":0.8309999704360962},{"id":"https://openalex.org/keywords/slc27a5","display_name":"SLC27A5","score":0.9789999723434448},{"id":"https://openalex.org/keywords/sirna-knockdown","display_name":"siRNA knockdown","score":0.8339999914169312},{"id":"https://openalex.org/keywords/hepatic-triglycerides","display_name":"hepatic triglycerides","score":0.9800000190734863},{"id":"https://openalex.org/keywords/fatty-acid-uptake","display_name":"fatty acid uptake","score":0.8790000081062317},{"id":"https://openalex.org/keywords/unconjugated-bile-acids","display_name":"unconjugated bile acids","score":0.875},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.8840000033378601},{"id":"https://openalex.org/keywords/mipomersen","display_name":"mipomersen","score":0.8759999871253967},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.6460000276565552},{"id":"https://openalex.org/keywords/long-chain-fatty-acid-uptake","display_name":"long-chain fatty acid uptake","score":0.6110000014305115},{"id":"https://openalex.org/keywords/hepatic-lipid-metabolism","display_name":"hepatic lipid metabolism","score":0.5830000042915344}],"concepts":[{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.878748893737793},{"id":"https://openalex.org/C2776175330","wikidata":"https://www.wikidata.org/wiki/Q1365091","display_name":"Steatosis","level":2,"score":0.8772889375686646},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.6421715021133423},{"id":"https://openalex.org/C543025807","wikidata":"https://www.wikidata.org/wiki/Q61476","display_name":"Fatty acid","level":2,"score":0.6285690665245056},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.5850589871406555},{"id":"https://openalex.org/C22894154","wikidata":"https://www.wikidata.org/wiki/Q15483409","display_name":"Lipidology","level":3,"score":0.536764919757843},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5322663187980652},{"id":"https://openalex.org/C382228","wikidata":"https://www.wikidata.org/wiki/Q849994","display_name":"Clinical chemistry","level":2,"score":0.4855603873729706},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4687279462814331},{"id":"https://openalex.org/C2779399885","wikidata":"https://www.wikidata.org/wiki/Q413288","display_name":"Bile acid","level":2,"score":0.46262145042419434},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.44655340909957886},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37640732526779175},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3603074550628662},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3402002453804016},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.2004413604736328},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19850337505340576},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.06665527820587158},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001055","descriptor_name":"Apolipoproteins B","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001055","descriptor_name":"Apolipoproteins B","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001647","descriptor_name":"Bile Acids and Salts","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005234","descriptor_name":"Fatty Liver","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D050612","descriptor_name":"Fatty Acid Transport Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055785","descriptor_name":"Gene Knockdown Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s11745-011-3596-3","doi":"https://doi.org/10.1007/s11745-011-3596-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11745-011-3596-3","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1007/s11745-011-3596-3","source":{"id":"https://openalex.org/S115623499","display_name":"Lipids","issn_l":"0024-4201","issn":["0024-4201","1558-9307"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lipids","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2224047","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3213337","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:21826528","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21826528","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lipids","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3213337","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3213337/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lipids","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s11745-011-3596-3","doi":"https://doi.org/10.1007/s11745-011-3596-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11745-011-3596-3","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1007/s11745-011-3596-3","source":{"id":"https://openalex.org/S115623499","display_name":"Lipids","issn_l":"0024-4201","issn":["0024-4201","1558-9307"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lipids","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1991920463.pdf","grobid_xml":"https://content.openalex.org/works/W1991920463.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W1968949098","https://openalex.org/W1977472360","https://openalex.org/W2008363902","https://openalex.org/W2008536703","https://openalex.org/W2009437300","https://openalex.org/W2019631541","https://openalex.org/W2023572044","https://openalex.org/W2025787794","https://openalex.org/W2030031111","https://openalex.org/W2045583819","https://openalex.org/W2048369172","https://openalex.org/W2053513183","https://openalex.org/W2059355578","https://openalex.org/W2062999279","https://openalex.org/W2070826050","https://openalex.org/W2071713779","https://openalex.org/W2080439716","https://openalex.org/W2081915217","https://openalex.org/W2081922902","https://openalex.org/W2083154566","https://openalex.org/W2084024458","https://openalex.org/W2091994022","https://openalex.org/W2095151181","https://openalex.org/W2095659152","https://openalex.org/W2096041374","https://openalex.org/W2107277218","https://openalex.org/W2107962891","https://openalex.org/W2113824754","https://openalex.org/W2116424844","https://openalex.org/W2116643669","https://openalex.org/W2116687544","https://openalex.org/W2121366725","https://openalex.org/W2129079051","https://openalex.org/W2143546514","https://openalex.org/W2145073911","https://openalex.org/W2151025672","https://openalex.org/W2152311269","https://openalex.org/W2153553829","https://openalex.org/W2154210359","https://openalex.org/W2155214511","https://openalex.org/W2318309546","https://openalex.org/W4243831105"],"related_works":["https://openalex.org/W2886437766","https://openalex.org/W2042876212","https://openalex.org/W2111767155","https://openalex.org/W2047547115","https://openalex.org/W2287351208","https://openalex.org/W4283371554","https://openalex.org/W2508696679","https://openalex.org/W2140218322","https://openalex.org/W1906772624","https://openalex.org/W2275599564"],"abstract_inverted_index":{"The":[0],"association":[1],"between":[2],"hypercholesterolemia":[3],"and":[4,46,64,123,145],"elevated":[5,61],"serum":[6],"apolipoprotein":[7],"B":[8],"(APOB)":[9],"has":[10],"generated":[11],"interest":[12],"in":[13,67,90,193],"APOB":[14,35],"as":[15,102],"a":[16,40,50,72],"therapeutic":[17],"target":[18],"for":[19,79,116],"patients":[20],"at":[21],"risk":[22],"of":[23,57,136,148,162,184,208],"developing":[24],"cardiovascular":[25],"disease.":[26],"In":[27],"the":[28,87,96,128,182,202,209],"clinic,":[29],"mipomersen,":[30],"an":[31],"antisense":[32],"oligonucleotide":[33],"(ASO)":[34],"inhibitor,":[36],"was":[37,164,178],"associated":[38],"with":[39,190],"trend":[41],"toward":[42],"increased":[43],"hepatic":[44,62,91,137,210],"triglycerides,":[45],"liver":[47,65,154],"steatosis":[48,66],"remains":[49],"concern.":[51],"We":[52,171],"found":[53],"that":[54,86,212],"siRNA-mediated":[55,160],"knockdown":[56,147,161,198],"ApoB":[58,168,215],"led":[59],"to":[60,70,104,140,166,180,200],"triglycerides":[63,92,138,211],"mice":[68,132,151],"engineered":[69],"exhibit":[71],"human-like":[73],"lipid":[74],"profile.":[75],"Many":[76],"genes":[77],"required":[78,115],"fatty":[80,99,105,119,142],"acid":[81,100,106,109,120,125,143,195],"synthesis":[82],"were":[83],"reduced,":[84],"suggesting":[85],"observed":[88],"elevation":[89],"is":[93,114],"maintained":[94],"by":[95,127],"cell":[97],"through":[98],"uptake":[101,122],"opposed":[103],"synthesis.":[107],"Fatty":[108],"transport":[110],"protein":[111],"5":[112],"(Fatp5/Slc27a5)":[113],"long":[117],"chain":[118],"(LCFA)":[121],"bile":[124,186,194],"reconjugation":[126],"liver.":[129],"Fatp5":[130,149,163,175,197],"knockout":[131],"exhibited":[133],"lower":[134],"levels":[135],"due":[139],"decreased":[141],"uptake,":[144],"shRNA-mediated":[146],"protected":[150],"from":[152],"diet-induced":[153],"steatosis.":[155,170],"Here,":[156],"we":[157],"evaluated":[158],"if":[159],"sufficient":[165,179],"alleviate":[167],"knockdown-induced":[169],"determined":[172],"that,":[173],"although":[174],"siRNA":[176,216],"treatment":[177],"increase":[181],"proportion":[183],"unconjugated":[185],"acids":[187],"100-fold,":[188],"consistent":[189],"FATP5's":[191],"role":[192],"reconjugation,":[196],"failed":[199],"influence":[201],"degree,":[203],"zonal":[204],"distribution,":[205],"or":[206],"composition":[207],"accumulated":[213],"following":[214],"treatment.":[217]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}
